Bruker
Open
$35.83
Prev. Close
$35.83
High
$35.85
Low
$35.83
Market Snapshot
$5.21B
-231.6
0.76
$3.37B
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Bruker launched MyGenius PRO and upgraded MALDI Biotyper tools, achieving a 9.55% seven-day return and a notable 24.63% year-to-date return in stock performance.
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Recently from Cashu
Bruker Positioned to Lead in U.S. Fusion Energy Development and Innovation
Bruker Positioned for Innovation in Fusion Energy Development The U.S. Department of Energy (DOE) is spearheading a transformative initiative to transition fusion energy from research laboratories to…
Bruker Enhances MRI Technology Leadership with New Supply Agreements in Superconductors
Bruker Strengthens Position in MRI Technology with New Supply Agreements Bruker Corporation, through its Bruker Energy & Supercon Technologies (BEST) division, has solidified its role in the healthcar…
Bruker Shows Resilience with Q3 Earnings Despite Revenue Decline Amid Market Challenges
Bruker Corporation's Resilience Amid Market Challenges Bruker Corporation reports its third-quarter earnings, showcasing a noteworthy resilience despite experiencing declines in both profit and revenu…
Bruker Set for Earnings Report: Focus on R&D and Market Position Insights
Bruker Gears Up for Key Earnings Announcement: Insights into R&D and Market Position Bruker, a prominent player in the scientific instruments sector, is poised to release its quarterly earnings on Nov…